Since the advent of antiretroviral treatments, the life expectancy of people living with HIV (PLHIV) has increased significantly. In France, more than 30% of PLHIV are now over 50 years old. This population is exposed to high multimorbidity, leading to frequent polypharmacy, defined as the regular use of at least five medications. Polypharmacy also has a qualitative dimension, including potentially inappropriate prescriptions. It increases the risk of adverse effects and drug interactions and impairs quality of life. A coordinated geriatric approach is therefore essential to optimize care. Healthy aging, promoted by the WHO, aims to improve the lives of older people. In this context, a study will be conducted at the Nice University Hospital among PLHIV aged 75 and over. It will collect quantitative data, the results of which will enable us to consider, if necessary, adapting the care pathways of these patients whose needs are complex.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
OTHER
Masking
NONE
Enrollment
136
45 to 60 minutes of interview
CHU de NICE
Nice, CHU de Nice, France
Describe polypharmacy among people living with HIV aged 75 and older.
The average number of medications taken
Time frame: 15 months
Assess the most common comorbidities associated with polypharmacy in the population of PLHIV aged 75
Number et type of comorbidities
Time frame: 15 months
Assess whether people taking multiple medications have a lower treatment adherence score than those taking fewer medications.
Score obtained on the Morisky MMAS-8 questionnaire
Time frame: 15 months
Assess the level of functional independence in this age group and link it to the existence of polypharmacy.
Lawton and Brody IADL scale
Time frame: 15 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.